Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Front Immunol ; 13: 861221, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35547739

RESUMO

Epigenetic reprogramming is an independent mode of gene expression that often involves changes in the transcription and chromatin structure due to tumor initiation and development. In this study, we developed a specifically modified peptide array and searched for a recognized epigenetic reader. Our results demonstrated that BRD4 is not only an acetylation reader but of propionylation as well. We also studied the quantitative binding affinities between modified peptides and epigenetic regulators by isothermal titration calorimetry (ITC). Furthermore, we introduced the Fgfr2-S252W transgenic mouse model to confirm that this acetylation is associated with the activation of c-Myc and drives tumor formation. Targeted disruption of BRD4 in Fgfr2-S252W mouse tumor cells also confirmed that BRD4 is a key regulator of histone 3 acetylation. Finally, we developed a tumor slice culture system and demonstrated the synergy between immune checkpoint blockade and targeted therapy in triple-negative breast cancer (TNBC). These data extend our understanding of epigenetic reprogramming and epigenetics-based therapies.


Assuntos
Neoplasias de Mama Triplo Negativas , Animais , Antígeno B7-H1/genética , Antígeno B7-H1/metabolismo , Proteínas de Ciclo Celular/genética , Proteínas de Ciclo Celular/metabolismo , Redes Reguladoras de Genes , Histonas/metabolismo , Humanos , Camundongos , Proteínas Nucleares/genética , Receptor de Morte Celular Programada 1/metabolismo , Receptor Tipo 2 de Fator de Crescimento de Fibroblastos/genética , Receptor Tipo 2 de Fator de Crescimento de Fibroblastos/metabolismo , Fatores de Transcrição/genética , Fatores de Transcrição/metabolismo , Neoplasias de Mama Triplo Negativas/tratamento farmacológico , Neoplasias de Mama Triplo Negativas/genética , Neoplasias de Mama Triplo Negativas/metabolismo
2.
J Am Chem Soc ; 142(42): 18150-18159, 2020 10 21.
Artigo em Inglês | MEDLINE | ID: mdl-32991157

RESUMO

Mimicking nature's ability to orchestrate molecular self-assembly in living cells is important yet challenging. Molecular self-assembly has found wide applications in cellular activity control, drug delivery, biomarker imaging, etc. Nonetheless, examples of suborganelle-confined supramolecular self-assembly are quite rare and research in this area remains challenging. Herein, we have presented a new strategy to program supramolecular self-assembly specifically in mitochondria by leveraging on a unique enzyme SIRT5. SIRT5 is a mitochondria-localized enzyme belonging to a family of NAD+-dependent histone deacetylases. Accumulating studies suggest that SIRT5 is involved in regulating diverse biological processes, such as reactive oxygen defense, fatty acid metabolism, and apoptosis. In this study, we designed a novel class of succinylated peptide precursors that can be transformed into self-assembling building blocks through SIRT5 catalysis, leading to the formation of supramolecular nanofibers in vitro and in living cells. The increased hydrophobicity arising from self-assembly remarkably enhanced the fluorescence of nitrobenzoxadiazole (NBD) in the nanofibers. With this approach, we have enabled activity-based imaging of SIRT5 in living cells for the first time. Moreover, SIRT5-mediated peptide self-assembly was found to depolarize mitochondria membrane potential and promote ROS formation. Coincubation of the peptide with three different chemotherapeutic agents significantly boosted the anticancer activities of these drugs. Our work has thus illustrated a new way of mitochondria-confined peptide self-assembly for SIRT5 imaging and potential anticancer treatment.


Assuntos
Mitocôndrias/metabolismo , Peptídeos/metabolismo , Sirtuínas/metabolismo , Biocatálise , Células HeLa , Humanos , Microscopia Eletrônica de Transmissão , Imagem Óptica , Peptídeos/síntese química , Peptídeos/química , Conformação Proteica
3.
ACS Appl Mater Interfaces ; 8(18): 11204-9, 2016 05 11.
Artigo em Inglês | MEDLINE | ID: mdl-27102225

RESUMO

A stimuli-responsive drug delivery system (DDS) with bioactive surface is constructed by end-capping mesoporous silica nanoparticles (MSNs) with functional peptide-coated gold nanoparticles (GNPs). MSNs are first functionalized with acid-labile α-amide-ß-carboxyl groups to carry negative charges, and then capped with positively charged GNPs that are decorated with oligo-lysine-containing peptide. The resulting hybrid delivery system exhibits endo/lysosomal pH triggered drug release, and the incorporation of RGD peptide facilitates targeting delivery to αvß3 integrin overexpressing cancer cells. The system can serve as a platform for preparing diversified multifunctional nanocomposites using various functional inorganic nanoparticles and bioactive peptides.


Assuntos
Nanopartículas Metálicas , Sistemas de Liberação de Medicamentos , Ouro , Humanos , Peptídeos , Porosidade , Dióxido de Silício
4.
Chem Commun (Camb) ; 51(97): 17273-6, 2015 Dec 18.
Artigo em Inglês | MEDLINE | ID: mdl-26463661

RESUMO

The development of hydrogels that are responsive to external stimuli in a well-controlled manner is important for numerous biomedical applications. Herein we reported the first example of a hydrogel responsive to hydrogen sulphide (H2S). H2S is an important gasotransmitter whose deregulation has been associated with a number of pathological conditions. Our hydrogel design is based on the functionalization of an ultrashort hydrogelating peptide sequence with an azidobenzyl moiety, which was reported to react with H2S selectively under physiological conditions. The resulting peptide was able to produce hydrogels at a concentration as low as 0.1 wt%. It could then be fully degraded in the presence of excess H2S. We envision that the novel hydrogel developed in this study may provide useful tools for biomedical research.


Assuntos
Hidrogéis/química , Sulfeto de Hidrogênio/química , Peptídeos/química , Microscopia Eletrônica de Transmissão
5.
Chem Commun (Camb) ; 49(77): 8644-6, 2013 Oct 07.
Artigo em Inglês | MEDLINE | ID: mdl-23948853

RESUMO

We report herein a new site-specific microarray immobilization method based on a biocompatible reaction between terminal cysteine and 2-cyanobenzothiazole (CBT). This immobilization strategy has been successfully applied to anchor small molecules, peptides and proteins onto microarrays.


Assuntos
Benzotiazóis/química , Cisteína/química , Proteínas Imobilizadas/química , Nitrilas/química , Peptídeos/química , Proteínas/química , Bibliotecas de Moléculas Pequenas/química , Animais , Adesão Celular , Camundongos , Modelos Moleculares , Células NIH 3T3 , Análise Serial de Proteínas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA